EnerSys to acquire Ultralife for $320 million
EnerSys (ENS) to acquire Ultralife (ULBI) for $320M, or $16 per share. The deal, expected to close in Q1 2027, aims to expand EnerSys's defense power platform. Ultralife generated $191M revenue in fiscal 2025. EnerSys expects $15-20M in annual cost synergies within 18 months.
How this was made

The 30-second read
Why it matters
The acquisition creates a larger, diversified defense battery platform, potentially improving market share and pricing power in a growing defense sector.
Market read
The $320 million deal is material for both companies and introduces a clear price catalyst for Ultralife shares while adding strategic depth to EnerSys.
What to watch
Regulatory approval risk and potential antitrust scrutiny in defense contracts could delay or alter the transaction.
Background
EnerSys (NYSE: ENS) is a global leader in stored energy solutions for industrial, infrastructure, and defense applications. Ultralife (NASDAQ: UL) supplies specialized batteries for military communications and other niche markets.
Ticker impact
EnerSys announced a definitive agreement to acquire Ultralife for $320 million at $16 per share in cash.
likely modest pressure as investors price in the cash outlay and integration risk, but long‑term upside from defense exposure.
The deal size is material for a mid‑cap (ENS) and the terms are disclosed for the first time, creating a clear near‑term valuation impact.
Market effects
Consolidation in the defense battery market may pressure peers such as Exide (XIDE) and Saft (SAFT) as EnerSys gains scale.
U.S. defense suppliers may see increased demand, while Ultralife's international operations could benefit from broader EnerSys distribution.
The deal highlights growing defense spending, potentially influencing broader industrial and aerospace sectors.
Counterpoint
If integration costs exceed expectations, EnerSys could face margin compression, making the deal less accretive.
Key entities
- ExecutiveShawn O’Connell
President and CEO of EnerSys, announced the acquisition.
- ExecutiveMichael Manna
President and CEO of Ultralife, commented on the deal.




